– –
This is exactly what we know at the moment, says Thomas Bremer from the Internet portal dieprüfung.de in Leipzig. We then assign the company to the environment of Dr. Heiner Pollert from Munich.
The entrepreneur about whom we published a few articles on dieevaluation.de in the last few days. Many of its companies are over-indebted on the balance sheet or have high losses from their business activities.
We have now received information from investors who have been made an offer to invest in a company that deals with the topic of “medical canabis”.
However, our investor “refrained from” the subject after he had already subscribed to another investment, which was also recommended to him by the investment advisor, although he had suffered a high loss.
Now we have also taken a closer look at this company. According to the last balance sheet published in the company register, Bavaria Weed GmbH is a company without equity, even with a 7-digit negative equity. Investing in such a company then certainly has to be considered carefully. We would certainly refrain from doing this.
The company advertises on its website as follows:
Our strategic partnership with EVE Cannabis from Canada
Eve & Co is a well-known company in the Canadian cannabis market. Through its own subsidiary Natural MedCo Ltd. Eve is a licensed producer and distributor of dried cannabis and cannabis plants under Canadian Medicinal Cannabis Products Regulations (ACMPR).
Third largest cannabis production in Canada
Eve Cannabis offers Bavaria Weed with its own cannabis production in Canada (approx. 22,000 m² of existing production area; current expansion to over 100,000 m²) a reliable supply of high-quality raw cannabis products.
Short delivery times and a transparent choice of types and active ingredients
We pack and sell raw cannabis products that we purchase in large quantities from our Canadian partner and can score points with a transparent selection of varieties and active ingredients, short delivery times and high delivery quality.
Quote end
What we have not found until today, according to Thomas Bremer from the internet portal dieversicherung.de, is some kind of prospectus, on the basis of which one may have collected there. From our point of view, according to the descriptions of our investor, a prospectus is required here to collect money. Since you want money from German investors here, this should of course be a prospectus approved by BaFin.
We now want to pursue the process even more intensively, also with regard to the business relationship between Bavaria Weed GmbH and the Canadian company.
Post Views:
38
–